Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah Meyran

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
The Journal of Clinical Investigation|June 16, 2020
Immune profiling of pediatric solid tumorsRachael L Terry, Deborah Meyran, David S Ziegler, et al.
Frontiers in Oncology|December 12, 2022
Advances in CAR T cell immunotherapy for paediatric brain tumoursPadmashree Rao, Liam Furst, Deborah Meyran, et al.
Biomedicines|December 24, 2021
Enhancing the Potential of Immunotherapy in Paediatric Sarcomas: Breaking the Immunosuppressive Barrier with Receptor Tyrosine Kinase InhibitorsEmmy D G Fleuren, Rachael L Terry, Deborah Meyran, et al.
Haematologica|November 5, 2020
PVRIG is a novel natural killer cell immune checkpoint receptor in acute myeloid leukemiaJessica Li, Sarah Whelan, Maya F Kotturi, et al.
Blood|October 10, 2014
The formin DIAPH1 (mDia1) regulates megakaryocyte proplatelet formation by remodeling the actin and microtubule cytoskeletonsJiajia Pan, Larissa Lordier, Deborah Meyran, et al.
European Journal of Cancer (Oxford, England : 1990)|August 18, 2020
Lymphoblastic predominance of blastic phase in children with chronic myeloid leukaemia treated with imatinib: A report from the I-CML-Ped StudyDeborah Meyran, Arnaud Petit, Joelle Guilhot, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|December 2, 2023
Infections in children following chimeric antigen receptor T-cell therapy for B-cell acute lymphoblastic leukemiaYonatan Diamond, Maddie Gilsenan, Stacie Shiqi Wang, et al.
Cancers|September 28, 2021
Chimeric Antigen Receptor T cell Therapy and the Immunosuppressive Tumor Microenvironment in Pediatric SarcomaRachael L Terry, Deborah Meyran, Emmy D G Fleuren, et al.
Transplantation and Cellular Therapy|February 8, 2025
Co-designing a Novel Ordinal Endpoint for an Adaptive Platform Trial, BANDICOOT, in Pediatric Hematopoietic Stem Cell TransplantHannah Walker, Lorna McLeman, Deborah Meyran, et al.
The EMBO Journal|December 6, 2019
PTPN2 phosphatase deletion in T cells promotes anti-tumour immunity and CAR T-cell efficacy in solid tumoursFlorian Wiede, Kun-Hui Lu, Xin Du, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
The Journal of Clinical Investigation|June 16, 2020
Immune profiling of pediatric solid tumorsRachael L Terry, Deborah Meyran, David S Ziegler, et al.
Frontiers in Oncology|December 12, 2022
Advances in CAR T cell immunotherapy for paediatric brain tumoursPadmashree Rao, Liam Furst, Deborah Meyran, et al.
Biomedicines|December 24, 2021
Enhancing the Potential of Immunotherapy in Paediatric Sarcomas: Breaking the Immunosuppressive Barrier with Receptor Tyrosine Kinase InhibitorsEmmy D G Fleuren, Rachael L Terry, Deborah Meyran, et al.
Haematologica|November 5, 2020
PVRIG is a novel natural killer cell immune checkpoint receptor in acute myeloid leukemiaJessica Li, Sarah Whelan, Maya F Kotturi, et al.
Blood|October 10, 2014
The formin DIAPH1 (mDia1) regulates megakaryocyte proplatelet formation by remodeling the actin and microtubule cytoskeletonsJiajia Pan, Larissa Lordier, Deborah Meyran, et al.
European Journal of Cancer (Oxford, England : 1990)|August 18, 2020
Lymphoblastic predominance of blastic phase in children with chronic myeloid leukaemia treated with imatinib: A report from the I-CML-Ped StudyDeborah Meyran, Arnaud Petit, Joelle Guilhot, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|December 2, 2023
Infections in children following chimeric antigen receptor T-cell therapy for B-cell acute lymphoblastic leukemiaYonatan Diamond, Maddie Gilsenan, Stacie Shiqi Wang, et al.
Cancers|September 28, 2021
Chimeric Antigen Receptor T cell Therapy and the Immunosuppressive Tumor Microenvironment in Pediatric SarcomaRachael L Terry, Deborah Meyran, Emmy D G Fleuren, et al.
Transplantation and Cellular Therapy|February 8, 2025
Co-designing a Novel Ordinal Endpoint for an Adaptive Platform Trial, BANDICOOT, in Pediatric Hematopoietic Stem Cell TransplantHannah Walker, Lorna McLeman, Deborah Meyran, et al.
The EMBO Journal|December 6, 2019
PTPN2 phosphatase deletion in T cells promotes anti-tumour immunity and CAR T-cell efficacy in solid tumoursFlorian Wiede, Kun-Hui Lu, Xin Du, et al.
Pageof 2